Format

Send to

Choose Destination
Kidney Int. 2020 Jan;97(1):10-13. doi: 10.1016/j.kint.2019.09.020.

Rationale and design of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study.

Author information

1
Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: townsend@upenn.edu.
2
Cardiometabolic Disease Research Department, Boehringer Ingelheim, Ridgefield, Connecticut, USA.
3
Division of Nephrology, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.
4
Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
5
Cardiovascular, Renal and Fibrosis Research, Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.
6
University of North Carolina Kidney Center, Chapel Hill, North Carolina, USA.
7
Inflammation & Respiratory Therapeutics, Gilead Sciences Inc., Foster City, California, USA.
8
Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
9
Division of Nephrology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York, USA.
10
Department of Human Genetics, GlaxoSmithKline, Collegeville, Pennsylvania, USA.
11
Office of Clinical Research, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
12
Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

KEYWORDS:

diabetic nephropathy; gene expression; glomerulus; kidney biopsy

PMID:
31901339
DOI:
10.1016/j.kint.2019.09.020

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center